Cures & Capital
Cures & Capital
Podcast Description
Hello and welcome to Cures & Capital - the podcast on value creation in biotech and pharma.Together, we are going to dive deep into the world of biotech and pharma to tackle the holy grail - how do we improve return on investment from drug innovation and deliver transformative therapies to patients, efficiently and sustainably.Hosted by Martin Slezak & Simon BirksøDisclaimer: This podcast and activities related to it are completely independent from our day jobs. All the views and opinions expressed through this channel are solely our own and do not represent or in any way reflect the views and opinions of the companies we work for.
Podcast Insights
Content Themes
The podcast explores topics around drug research and development (R&D), investment strategies, and business models in the pharmaceutical industry, with episodes addressing issues like declining ROI in drug innovation and decision-making in R&D, featuring in-depth discussions with experts in the field.
Hello and welcome to Cures & Capital – the podcast on value creation in biotech and pharma.
Together, we are going to dive deep into the world of biotech and pharma to tackle the holy grail – how do we improve return on investment from drug innovation and deliver transformative therapies to patients, efficiently and sustainably.
Hosted by Martin Slezak & Simon Birksø
Disclaimer: This podcast and activities related to it are completely independent from our day jobs. All the views and opinions expressed through this channel are solely our own and do not represent or in any way reflect the views and opinions of the companies we work for.
In this episode, we talk to Dr. Andrée Bates, founder and CEO of Eularis, a company helping clients accelerate pharma business results through Artificial Intelligence.
We explore how the biopharma industry can move beyond scattered pilots toward strategic, enterprise-wide AI integration. Drawing on decades at the forefront of AI in pharma, Dr. Bates shares practical insights on building the foundations for long-term value creation and turning AI into a true competitive advantage. We also dig into how to calculate ROI on AI, avoid the “spray and pray” trap, and why the future of pharma might look more like science fiction than we think.
If you want to connect with us – we would love to hear from you:
Linkedin: https://www.linkedin.com/company/cures-capital-podcast
You can also watch this episode on YouTube, just search for Cures & Capital.
If you want to connect withDr. Andrée Bates:
Linkedin: https://www.linkedin.com/in/dr-andree-bates/
Or get in touch with Eularis:
Linkedin: https://www.linkedin.com/company/eularis/
Website: https://eularis.com
If you would like to read Romy & Roby:
Website: https://romyandroby.ai
Disclaimer: This podcast and activities related to it are completely independent from our day jobs. All the views and opinions expressed through this channel are solely our own and do not represent or in any way reflect the views and opinions of the companies we work for.
Disclaimer
This podcast’s information is provided for general reference and was obtained from publicly accessible sources. The Podcast Collaborative neither produces nor verifies the content, accuracy, or suitability of this podcast. Views and opinions belong solely to the podcast creators and guests.
For a complete disclaimer, please see our Full Disclaimer on the archive page. The Podcast Collaborative bears no responsibility for the podcast’s themes, language, or overall content. Listener discretion is advised. Read our Terms of Use and Privacy Policy for more details.